No Detail Found!

Apoptosis induction, cell cycle arrest, and tumor genes expression analysis of tamoxifen and ivermectin loaded chitosan nanoparticles against MCF-7 Cell line

Author(s)
Usama bin Naeem Department of Pharmacology and Toxicology, Faculty of Biosciences, University of Veterinary and Animal Sciences Lahore,,Pakistan
Muhammad Adil Rasheed Department of Pharmacology and Toxicology, Faculty of Biosciences, University of Veterinary and Animal Sciences Lahore,,Pakistan
Muhammad Ashraf Department of Pharmacology and Toxicology, Faculty of Biosciences, University of Veterinary and Animal Sciences Lahore,,Pakistan
Muhammad Yasir Zahoor Insititue of Biochemistry and Biotechnology, Faculty of Biosciences, University of Veterinary and Animal Sciences Lahore,,Pakistan
Abstract
One of the most dominant diseases in the world, particularly among women, is breast cancer. Breast cancer has tumor suppressor genes called CHEK2 and TP53. When there is a mutation in CHEK2 and TP53 genes there are more chances of breast cancer. This study aimed to investigate the already prepared and characterized nanoparticles loaded with Chitosan for Cell death, Mitochondrial Membrane and cell cycle arrest estimated through Flow Cytometry and gene expression analysis of CHEK2 and TP53 genes by real-time PCR. The Livak method was used to evaluate the results. The mean (± S.D) comparison between the control and target genes were used to calculate gene expression. Results showed that Ivermectin and Tamoxifen NPs (B+C) represented 34.8% cell death that is better than other combinations with propidium iodide stain while with Acridine orange stain Tamoxifen+Ivermectin (A+B) combination showed the remarkable and maximum of the all cell cycle arrest with value of 69.7% cell arrest at G0/G1 phase, 7.11% of cell arrest at S Phase and 7.05% of G2/M Phase arrest. It was demonstrated that the expression levels of CHEK2 and TP53 genes were significantly increased (P<0.001) in Ivermectin+Tamoxifen NPs (B+C) compared with control groups. It is concluded that Tamoxifen nanoparticles with Ivermectin showed strong anti-proliferative activity against breast cancer cells. The expression levels of nanoparticles containing Tamoxifen were significantly increased compared to the other treatments and control groups (P<0.001). Gene expression change with change in dose concentrations.
Publication Details
Page(s) 1-11
Published Journal: Asian Journal of Agriculture and Biology, Volume: 1, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
Apoptosis, Breast Cancer, gene expression, cell cycle arrest, Pharmacogenomic
References
Amatori S,Mazzoni L,Alvarez-Suarez M,Giampieri F,Gasparrini M,Forbes-Hernandez Y,Afrin S,Errico Provenzano A,Persico G,Mezzetti B,Amici A .2016 .Polyphenol-rich strawberry extract (PRSE) shows in vitro and in vivo biological activity against invasive breast cancer cells. Scient. Reports, 6(1) : 09-17.
Amatori S,Persico G,Fanelli M .2017 .Real-time quantitative PCR array to study drug-induced changes of gene expression in tumor cell lines. J. Cancer Metastasis Treat, 3(90) : 10-20.
Ataollahi R,Sharifi J,Paknahad R,Paknahad A .2015 .Breast cancer and associated factors: a review. J. Med. life. 8, (4) : 6.
Badawy A,Othman A,El-Magd A .2021 .Effect of combined therapy with camel milk-derived exosomes, tamoxifen, and hesperidin on breast cancer. Mol. Cell. Toxicol. doi:10.1007/s13273- 021-00163-4, : .
Chae J,Bae S,Lee A,Park C,Seo J,Song J,Kim S,Jung S .2009 .p53 as a specific prognostic factor in triple-negative breast cancer. Japan. J. Clin. Oncol, 39(4) : 217-224.
Cybulski C,Wokołorczyk D,Jakubowska A,Huzarski T,Byrski T,Gronwald J,Dębniak T,Górski B,Narod A,Lubiński J .2012 .The risk of breast cancer in women with a CHEK2 mutation. Heredi. Canc. Clini. Prac, 10 : 1-1.
Dou N,Chen K,Wang K,Yuan Y,Lei K,Li J,Lan Y,Chen Z,Huang N,Xie L,Zhang R,Xiang C,Nice Y,Wei C .2016 .Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer. Cancer Res, 76(15) : 4457-4469.
Deng F,Xu Q,Long J,Xie H .2018 .Suppressing ROS-TFE3-dependent autophagy enhances ivermectin-induced apoptosis in human melanoma cells. J. Cell. Biochem, 120 : 1702-1715.
Gluz O,Liedtke C,Gottschalk N,Pusztai L,Nitz U,Harbeck N .2009 .Triple-negative breast cancer-current status and future directions. , 20(12) : 1913-1927.
Gutiérrez‐Enríquez S,Bonache S,Ruíz de Garibay G,Osorio A,Santamariña M,Ramón y Cajal T,Esteban‐Cardeñosa E,Tenés A,Yanowsky K,Barroso A,Montalban G .2014 .About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants. Int. J. Can, 134(9) : 2088-2097.
Güler M,Günaydin A .2022 .Ivermectin induces oxidative stress and DNA damage in breast cancer cells. Bezmialem Sci, 10(1) : 15-22.
El-Magd MA,Mohamed Y,El-Shetry ES,Elsayed SA,Abo Gazia M,Abdel-Aleem GA,Shafk NM,Abdo WS,El-Desouki NI,Basyony MA .2019 .Melatonin maximizes the therapeutic potential of non-preconditioned MSCs in a DENinduced rat model of HCC. , 114 : 108-732.
Guney Eskiler G,Cecener G,Dikmen G,Egeli U,Tunca B .2018 .Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer. Eur. J. Pharma. Sci, 04 : 73-88.
Jaafari A,Tilaoui M,Mouse A,M'bark A,Aboufatima R,Chait A,Lepoivre M,Zyad A .2012 .Comparative study of the antitumor effect of natural monoterpenes: relationship to cell cycle analysis. Rev. Brasil. Farmacogn, 22(3) : 534-540.
Jeromin S,Eder C,Haferlach C,Haferlach T,Kern W .2019 .Impact of assay procedures on detection of MR4. 5 status in chronic myeloid leukemia: Optimization of cDNA synthesis. Int. J. Lab. Hema, 41(5) : 109-112.
Juarez M,Schcolnik-Cabrera A,Dominguez-Gomez G,ChavezBlanco A,Diaz-Chavez J,DuenasGonzalez A .2020 .Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug. Canc. Chemother. Pharmacol, 85(11) : 53-63.
Kumpula A,Koivuluoma S,Soikkonen L,Vorimo S,Moilanen J,Winqvist R,Mantere T,Kuismin O,Pylkäs K .2023 .Evaluating the role of CHEK2 p.(Asp438Tyr) allele in inherited breast cancer predisposition. Famil. Can. 1-4., : .
Li W,Ma G,Deng Y,Wu Q,Wang Z,Zhou Q .2021 .Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhibiting MAPK pathway. Gene, 766 : 145134.
Liu W,Gravett A,Dalgleish A .2011 .The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies. Int. J. Canc, 15 : 1471-1480.
Mahmood Q,Shaheen S,Azeem M .2024 .Nanobiosensors: application in healthcare, environmental monitoring and food safety. Asian J. Agric. Biol, : 2023157.
.2023 .. , : .
Mitas M,Mikhitarian K,Walters C,Baron L,Elliott M,Brothers E,Robison G,Metcalf S,Palesch Y,Gillanders Z,E Z .2001 .Quantitative real‐time RT‐PCR detection of breast cancer micrometastasis using a multigene marker panel. Int. J. Can, 93(2) : 162-171.
Näslund-Koch C,Nordestgaard G,Bojesen E .2016 .Increased risk for other cancers in addition to breast cancer for CHEK2* 1100delC heterozygotes estimated from the Copenhagen general population study. J. Clin. Oncol, 34(11) : 1208-1216.
Ocker M,Schneider-Stock R,Biochem Int. J. .2007 .Histone deacetylase inhibitors: signalling towards p21cip1/waf1.. Cell bio, 39(7-8) : 1367-1374.
Olbromski J,Pawlik P,Bogacz A,Sajdak S .2022 .Identification of New Molecular Biomarkers in Ovarian Cancer Using the Gene Expression Profile. J. Clini. Med, 11(13) : 3888.
Olivier M,Langerd A,Carrieri P,Bergh J,Klaar S,Eyfjord J,Theillet C,Rodriguez C,Lidereau R,Biche I,Varley J .2006 .The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clinical cancer research. J. Amer. Assoc. Canc. Res, 12(4) : 1157-1167.
Rudloff U,Bhanot U,Gerald W,Klimstra S,Jarnagin R,Brennan F,Allen J .2010 .Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality. Annals of surgical oncology, 17 : 2229-2236.
Sharma S,Sambyal V,Guleria K,Manjari M,Sudan M,Uppal S,Singh R,Bansal D,Gupta A .2014 .TP53 polymorphisms in sporadic North Indian breast cancer patients. Asian Pac. J. Canc. Preven, 15(16) : 6871-6879.
Seresht R,Albadry J,Al-mosawi M,Gholami O,Cheshomi H .2019 .The cytotoxic effects of thymol as the major component of Trachyspermum ammi on breast cancer (MCF-7) cells. Pharma. Chem. J, 53 : 101-107.
Wiesmüller L .2001 .Genetic stabilization by p53 involves growth regulatory and repair pathways. J. Biomed. Biotech, 1(1) : 7-10.
Wisesty N,Mengko R,Purwarianti A .2020 .Gene mutation detection for breast cancer disease: A review. In IOP Conference Series: Mate. Sci. Engin, 3 : 032051.
0

Citations

0

Downloads

36

Views